Last reviewed · How we verify
NCT04795765
SpineJack System Postmarket Registry
trial testing SpineJack system in Osteoporotic Vertebral Compression Fractures in 261 participants. Completed in 11 November 2024.
11 November 2024
Quick facts
| Lead sponsor | Stryker Instruments |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 261 |
| Start date | 19 August 2019 |
| Primary completion | 11 November 2024 |
| Estimated completion | 11 November 2024 |
| Sites | 12 locations across United States |
Drugs / interventions tested
- SpineJack system
- Balloon kyphoplasty
- Vertebroplasty
Conditions studied
- Osteoporotic Vertebral Compression Fractures — all drugs for Osteoporotic Vertebral Compression Fractures →
Sponsor
Stryker Instruments — full company profile →
Who can join
18 and older, any sex, with Osteoporotic Vertebral Compression Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This postmarket registry is intended to prospectively collect real world data to support ongoing safety and performance of the SpineJack system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04795765
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SpineJack system
Trials testing the same drug.
- NCT02657265 — SpineJack® Versus Conservative Treatment Study (SPICO Study) · NA · completed
Other recruiting trials for Osteoporotic Vertebral Compression Fractures
Currently open trials in the same condition.
- NCT06270173 — Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures · NA · active not recruiting
- NCT06261242 — Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures Treatment · NA · active not recruiting
Other Stryker Instruments trials
Trials by the same sponsor.
- NCT07392333 — Prospective Study of Basivertebral Nerve Ablation With the OptaBlate BVN System for Vertebrogenic Low Back Pain · not yet recruiting
- NCT04154605 — ClariFix Rhinitis RCT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04795765 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stryker Instruments
- Last refreshed: 10 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04795765.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing